Search Results for: CPRX
by H.S. AyoubBioHealth Investor.com Biotechnology DENDREON CORP [DNDN] +10.29% NORTHFIELD LABS IN [NFLD] +10.25% COMBINATORX [CRXX] +9.56% ONYX PHARM INC [ONXX] +8.70% SEQUENOM INC [SQNM] +8.08%...
Published:
Catalyst Pharmaceuticals saw its shares get halved just Tuesday morning alone, following a business update regarding its Lambert-Eaton myasthenic syndrome treatment.
Published:
Last Updated:
Some small-cap companies will screen as having deep value, but many value stocks are deemed to be "cheap" because they lack any new catalysts and opportunities.
Published:
Robinhood has become the dominant discount brokerage platform over the last year. It had 4.3 million average revenue trades in June, which is a critical metric in the industry. This is higher than...
Published:
Wednesday's additional top analyst upgrades and downgrades were on Amazon.com, Beyond Meat, Catalyst Pharmaceuticals, Dick’s Sporting Goods, Macy’s, Medtronic, Twitter, XPeng and more.
Published:
Rite Aid has announced that it will acquire EnvisionRx for $2 billion from the private equity firm TPG Capital.
Published:
Source: ThinkstockCatalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) announced positive topline results from its Phase 3 clinical trial of Firdapse for the symptomatic treatment of Lambert-Eaton...
Published:
Some companies Robinhood traders find most attractive are very risky bets. A hit to the financials of one of these companies or a piece of bad news could easily trigger an extreme sell-off of the...
Published:
Apple, Twitter and other companies punished shareholders last week, and analysts expect more earnings disappointments going forward.
Published:
Last Updated:
The broad markets are inching forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) is up about 1% on the day,...
Published:
Last Updated:
The the top analyst upgrades, downgrades and initiations seen on Wednesday morning include Broadcom, Flex, Genworth Financial, Micron Technology, Salesforce.com, UBS and Wal-Mart.
Published:
Last Updated:
A new SunTrust Robinson Humphrey research report focuses in on biotech companies that have upcoming clinical data that could prove to be huge.
Published:
Last Updated:
In the week of October 7, there were multiple analyst calls for stocks to buy that were trading under $10 per share, including Petrobras and Brocade Communications.
Published:
Last Updated:
Tuesday's top analyst upgrades and downgrades included Applied Materials, Bill, Catalyst Pharmaceutical, CVS Health, Elastic, Hawaiian Electric Industries and Walmart.
Published:
Celator Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering.
Published:
Last Updated: